NPs Basic Information

Name
Scopoletin
Molecular Formula C10H8O4
IUPAC Name*
7-hydroxy-6-methoxychromen-2-one
SMILES
COC1=C(C=C2C(=C1)C=CC(=O)O2)O
InChI
InChI=1S/C10H8O4/c1-13-9-4-6-2-3-10(12)14-8(6)5-7(9)11/h2-5,11H,1H3
InChIKey
RODXRVNMMDRFIK-UHFFFAOYSA-N
Synonyms
scopoletin; 92-61-5; Gelseminic acid; 7-Hydroxy-6-methoxy-2H-chromen-2-one; 6-Methylesculetin; Chrysatropic acid; Scopoletine; 7-Hydroxy-6-methoxycoumarin; Murrayetin; Scopoletol; Escopoletin; 6-O-Methylesculetin; 6-Methoxy-7-hydroxycoumarin; 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-; 6-Methoxyumbelliferone; Esculetin 6-methyl ether; 7-hydroxy-6-methoxychromen-2-one; beta-Methylesculetin; Buxuletin; .beta.-Methylesculetin; Esculetin-6-methyl ether; Baogongteng B; COUMARIN, 7-HYDROXY-6-METHOXY-; NSC 405647; KLF1HS0SXJ; 7-hydroxy-6-methoxy-chromen-2-one; NSC405647; NSC-405647; CHEMBL71851; CHEBI:17488; Gelseminic acid;Chrysatropic acid; TNP00096; Chrysotropic Acid; Acid, Gelseminic; Acid, Chrysotropic; SMR000112541; CCRIS 3592; SR-01000841273; UNII-KLF1HS0SXJ; EINECS 202-171-9; MFCD00006872; BRN 0156296; b-Methylaesculetin; beta -methylesculetin; COPOLETIN; Scopoletin, >=99%; SCOPOLETIN [MI]; Prestwick0_000962; Prestwick1_000962; Prestwick2_000962; Prestwick3_000962; Spectrum2_001207; Spectrum3_001532; Spectrum4_001054; Spectrum5_000654; Aesculetin 6-methyl ether; SCOPOLETIN [USP-RS]; BIDD:PXR0125; BSPBio_000963; BSPBio_002944; KBioGR_001348; 5-18-03-00203 (Beilstein Handbook Reference); 7-hydroxy-6-methoxy-coumarin; MLS002154074; MLS002472878; DivK1c_000720; SCHEMBL147702; SPECTRUM1502242; 7-hydroxy 6-methoxy coumarine; SPBio_000994; SPBio_002884; Scopoletin, analytical standard; BPBio1_001061; MEGxp0_001192; DTXSID0075368; ACon1_000143; HMS502D22; KBio1_000720; KBio3_002444; ZINC57733; NINDS_000720; HMS1571A05; HMS1921N16; HMS2098A05; HMS2268G04; HMS3885K10; ALBB-023369; BCP13342; HY-N0342; 6-methoxy-7-oxidanyl-chromen-2-one; BDBM50156693; CCG-39140; s3881; STL570289; TD8126; AKOS000277133; CS-5791; CAS-92-61-5; IDI1_000720; 7-hydroxy-6-methoxy-1-benzopyran-2-one; NCGC00016349-01; NCGC00016349-02; NCGC00016349-03; NCGC00016349-04; NCGC00016349-05; NCGC00016349-06; NCGC00016349-07; NCGC00016349-08; NCGC00094973-01; NCGC00094973-02; NCGC00094973-03; AC-34125; AS-65759; NCI60_003834; 7-Hydroxy-6-methoxy-2H-chromen-2-one #; DB-050232; AB00443525; FT-0631451; S0367; C01752; S-2000; 006S872; A844290; Q2472366; SR-01000841273-3; SR-01000841273-4; BRD-K96163925-001-06-5; BRD-K96163925-001-09-9; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- (9CI); 0B4B9FAA-686D-4977-AA08-65F8E4F1977C; SCOPOLETIN (CONSTITUENT OF STINGING NETTLE) [DSC]; Scopoletin, United States Pharmacopeia (USP) Reference Standard; T83
CAS 92-61-5
PubChem CID 5280460
ChEMBL ID CHEMBL71851
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Phenylpropanoids and poly
      • Class: Coumarins and derivatives
        • Subclass: Hydroxycoumarins
          • Direct Parent: 7-hydroxycoumarins

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 192.17 ALogp: 1.5
HBD: 1 HBA: 4
Rotatable Bonds: 1 Lipinski's rule of five: Accepted
Polar Surface Area: 55.8 Aromatic Rings: 2
Heavy Atoms: 14 QED Weighted: 0.702

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.725 MDCK Permeability: 0.00001630
Pgp-inhibitor: 0.003 Pgp-substrate: 0.945
Human Intestinal Absorption (HIA): 0.009 20% Bioavailability (F20%): 0.236
30% Bioavailability (F30%): 0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.157 Plasma Protein Binding (PPB): 83.62%
Volume Distribution (VD): 0.689 Fu: 19.39%

ADMET: Metabolism

CYP1A2-inhibitor: 0.971 CYP1A2-substrate: 0.948
CYP2C19-inhibitor: 0.181 CYP2C19-substrate: 0.078
CYP2C9-inhibitor: 0.052 CYP2C9-substrate: 0.85
CYP2D6-inhibitor: 0.487 CYP2D6-substrate: 0.878
CYP3A4-inhibitor: 0.305 CYP3A4-substrate: 0.292

ADMET: Excretion

Clearance (CL): 13.312 Half-life (T1/2): 0.85

ADMET: Toxicity

hERG Blockers: 0.09 Human Hepatotoxicity (H-HT): 0.245
Drug-inuced Liver Injury (DILI): 0.814 AMES Toxicity: 0.06
Rat Oral Acute Toxicity: 0.069 Maximum Recommended Daily Dose: 0.372
Skin Sensitization: 0.555 Carcinogencity: 0.595
Eye Corrosion: 0.358 Eye Irritation: 0.978
Respiratory Toxicity: 0.233
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001561 0.667 D08SKH 0.417
ENC001524 0.569 D0E9CD 0.408
ENC001623 0.537 D07MGA 0.351
ENC001562 0.521 D06GCK 0.350
ENC001367 0.490 D0DJ1B 0.303
ENC001539 0.442 D00CSQ 0.284
ENC005717 0.429 D05CKR 0.279
ENC005716 0.429 D04AIT 0.276
ENC000078 0.417 D08ZEB 0.273
ENC002901 0.415 D0K8KX 0.269
*Note: the compound similarity was calculated by RDKIT.